TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis.

Hsiang-Fong Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.